These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7465187)

  • 1. [Incidence of HLA-antigens and cytotoxic capacity of lymphocytes in patients with breast cancer].
    Garam T; Gyódi E; Bakács T; Svastits E; Petrányi G
    Orv Hetil; 1980 Sep; 121(38):2323-6. PubMed ID: 7465187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of anti-HLA immunization in pregnancy (author's transl)].
    Arenzana Seisdedos F; Garzón García M; Núñez Roldán A
    Sangre (Barc); 1982; 27(1):1-6. PubMed ID: 7101090
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocytotoxic antibodies in Israeli patients with rheumatoid arthritis.
    Livneh A; Renert A; Avishai O; Langevitz P; Gazit E
    Isr J Med Sci; 1997 Jan; 33(1):30-5. PubMed ID: 9203515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G and its KIR ligands in cancer--another enigma yet to be solved?
    Urosevic M; Trojan A; Dummer R
    J Pathol; 2002 Mar; 196(3):252-3. PubMed ID: 11857486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T
    Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    Linehan DC; Goedegebuure PS; Peoples GE; Rogers SO; Eberlein TJ
    J Immunol; 1995 Nov; 155(9):4486-91. PubMed ID: 7594611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose.
    Remberger M; Mattsson J; Svahn BM; Ringdén O
    Bone Marrow Transplant; 2008 Dec; 42(11):769-71. PubMed ID: 18695663
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of maternal lymphocytotoxins using various sources of lymphocytes.
    Sujirachato K; Chiewsilp P
    J Med Assoc Thai; 1988 Feb; 71(2):100-4. PubMed ID: 3361256
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
    Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
    Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43.
    Reinerová M; Veselovská Z; Ausch C; Rosen HR
    Neoplasma; 1996; 43(6):363-6. PubMed ID: 8996559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
    Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
    J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients.
    Suefuji Y; Sasatomi T; Shichijo S; Nakagawa S; Deguchi H; Koga T; Kameyama T; Itoh K
    Br J Cancer; 2001 Apr; 84(7):915-9. PubMed ID: 11286471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
    Narayanan K; Jaramillo A; Benshoff ND; Campbell LG; Fleming TP; Dietz JR; Mohanakumar T
    J Natl Cancer Inst; 2004 Sep; 96(18):1388-96. PubMed ID: 15367572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy.
    Carlsson B; Forsberg O; Bengtsson M; Tötterman TH; Essand M
    Prostate; 2007 Mar; 67(4):389-95. PubMed ID: 17219382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytotoxins in infectious mononucleosis: a non-cytotoxic effect on lymphocytes at 37 degrees C and the influence of cell metabolism on their cytotoxicity in vitro.
    Quin JW; Charlesworth JA; Yasmeen D; Macdonald GJ; Pussell BA
    Clin Exp Immunol; 1981 Feb; 43(2):285-90. PubMed ID: 7273482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers.
    Bharat A; Benshoff N; Fleming TP; Dietz JR; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2008 Aug; 110(3):453-63. PubMed ID: 17874294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation.
    Tinckam KJ; Wood IG; Ji F; Milford EL
    Hum Immunol; 2004 Nov; 65(11):1281-7. PubMed ID: 15556678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.